Atara Biotherapeutics, Inc. reports

Company location: Thousand Oaks, CA
Fiscal year end: 31 December

Atara Biotherapeutics, Inc. has filed 1,129 SEC EDGAR filings since 10 Apr 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 626-650 of 1,000 matching filings.

Per page

25

Current page

26

4

FORM 4 SUBMISSION

Filing date: 12 Sep 2018
Reporting date: 11 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 12 Sep 2018
Reporting date: 11 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36548

8-K

Filing date: 12 Sep 2018
Reporting date: 11 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Sep 2018
Reporting date: 27 Jul 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Sep 2018
Reporting date: 06 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88393

SC 13G/A filing

Filing date: 10 Sep 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Sep 2018
Reporting date: 04 Sep 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 Aug 2018
Reporting date: 20 Aug 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-36548

CT ORDER filing

Filing date: 20 Aug 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Aug 2018
Reporting date: 15 Aug 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Aug 2018
Reporting date: 15 Aug 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Aug 2018
Reporting date: 06 Aug 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Aug 2018
Reporting date: 01 Aug 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36548

10-Q

Filing date: 01 Aug 2018
Reporting date: 30 Jun 2018
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36548

8-K

Filing date: 01 Aug 2018
Reporting date: 01 Aug 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Jul 2018
Reporting date: 30 Jul 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Jul 2018
Reporting date: 26 Jul 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Jul 2018
Reporting date: 09 Jul 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 Jun 2018
Reporting date: 26 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Jun 2018
Reporting date: 18 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 Jun 2018
Reporting date: 14 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 Jun 2018
Reporting date: 14 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36548

8-K

Filing date: 18 Jun 2018
Reporting date: 14 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 Jun 2018
Reporting date: 14 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 Jun 2018
Reporting date: 14 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .